GLP-1 Semaglutide – A Breakthrough in Weight Management & Metabolic Health

Overview

Semaglutide is a synthetic GLP-1 (Glucagon-Like Peptide-1) receptor agonist, widely studied and approved for type 2 diabetes and obesity management. It works by enhancing insulin secretion, slowing gastric emptying, and reducing appetite.

Read more “GLP-1 Semaglutide – A Breakthrough in Weight Management & Metabolic Health”